Long-term circulatory support with a left ventricular assist device therapy in Japan

Circulation Journal

Volumn 74, Issue 4, 2010, Pages 624-625

  Saito, Satoshi ^a   Nishinaka, Tomohiro ^a   Yamazaki, Kenji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APACHE; ASSISTED CIRCULATION; DEVICE THERAPY; EDITORIAL; HEART ASSIST DEVICE; HEART LEFT VENTRICLE ASSIST DEVICE; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; IMPLANTATION; JAPAN; LONG TERM CARE; MORTALITY; OUTCOME ASSESSMENT; PROSTHESIS FAILURE; SCORING SYSTEM; SURVIVAL RATE; TREATMENT INDICATION;

BLOOD CIRCULATION; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; JAPAN; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77950824678     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0164     Document Type: Editorial

References (14)

1. Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, et al. Risk factor analysis of long-term support with left ventricular assist system. Circ J 2010; 74: 715-722.
2. Deng MC, Loebe M, El Banayosy A, Gronda E, Jansen PGM, Vigano M, et al. Mechanical circulatory support for advanced heart failure: Effect of patient selection on outcome. Circulation 2001; 103: 231-237.
3. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003; 125: 855-862.
4. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829.
5. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: Prediction of survival in heart failure. Circulation 2006; 113: 1424-1433.
6. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson SM, Catanese KA, et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation 1995; 92(Suppl): II-169-II-173.
7. Miller LW, Lietz K. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant 2006; 25: 756-764.
8. Deng MC, Edwards LB, Hertz MI, Rowe A, Keck B, Kormos R, et al. Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: Third Annual Report-2005. J Heart Lung Transplant 2005; 24: 1182-1187.
9. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006; 25: 1-6.
10. Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion, Ann Thoracic Surg 1999; 68: 2181-2184.
11. Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: Analysis of 245 patients. Circulation 2002; 106: 198-202.
12. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251.
13. Yamazaki K, Kihara S, Akimoto T, Tagusari O, Kawai A, Umezu M, et al. EVAHEART: An implantable centrifugal blood pump for long-term circulatory support. Jpn J Thorac Cardiovasc Surg 2002; 50: 461-465.
14. Yamazaki K, Saito S, Kihara S, Tagusari O, Kurosawa H. Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump: Mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg 2007; 55: 158-162.